HomeClinical TopicsFDA approves Onfi for seizures associated with Lennox-Gastaut syndrome

FDA approves Onfi for seizures associated with Lennox-Gastaut syndrome

The U.S. Food and Drug Administration has approved Onfi (clobazam) for use as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

Pregnant woman drinking coffee

Cup of Coffee Can Lessen Gestational Diabetes Risk

Pregnant mothers concerned about being able to safely enjoy their morning cup of coffee should be reassured by a recent University of Pennsylvania study...